Correlation of dual-source computed tomography/dual-energy imaging with pathological grading of lung adenocarcinoma and its clinical value
- PMID: 29492072
- PMCID: PMC5768838
- DOI: 10.12669/pjms.336.13320
Correlation of dual-source computed tomography/dual-energy imaging with pathological grading of lung adenocarcinoma and its clinical value
Abstract
Objective: To explore the correlation of dual-source computed tomography (DSCT)/dual-energy imaging with pathological grading of lung adenocarcinoma.
Methods: A total of 47 patients with lung adenocarcinoma were selected. Tissues were histopathologically confirmed by routine DSCT scanning and dual-energy enhanced scanning. Arterial-phase and venous-phase iodine distribution images and single-energy images at 40-190 keV were obtained. The region of interest was outlined to obtain CT values. The iodine concentrations of each tumor in two phases were recorded to calculate normalized iodine concentrations (NICs).
Results: The maximum diameter and minimum diameter of tumors in low differentiation (LD) group were significantly higher than those of high differentiation (HD) group (P<0.05). In LD group, 70.8% of margins were lobulated, which significantly exceeded that of HD group (30.4%) (P<0.05). Besides, 26.1% of patients in HD group were complicated with ground-glass opacity, which was significantly higher than that of LD group (4.2%) (P<0.05). In venous phase, there were significant differences between the two groups at low energy levels (40-70 keV) (P<0.05). At high energy levels (80-190 keV), the CT values of LD group were slightly higher than those of HD group. In arterial and venous phases, NICs of HD group were lower than those of LD group (P>0.05).
Conclusion: HD and LD groups could be predictably distinguished by single-energy images at low energy levels (40-70 keV) in the venous phase. Quantitative analysis of NIC in the venous phase is also valuable for predicting the pathological grade of lung adenocarcinoma.
Keywords: Dual-source computed tomography; Lung Adenocarcinoma; Pathological grade.
Conflict of interest statement
Declaration of interest: None.
Similar articles
-
A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase.Acad Radiol. 2020 May;27(5):624-629. doi: 10.1016/j.acra.2019.07.018. Epub 2019 Aug 22. Acad Radiol. 2020. PMID: 31447258
-
Application Value of Spectral CT Imaging in Quantitative Analysis of Early Lung Adenocarcinoma.J Oncol. 2022 Mar 16;2022:2944473. doi: 10.1155/2022/2944473. eCollection 2022. J Oncol. 2022. PMID: 35342413 Free PMC article.
-
[Differential diagnosis of pure ground glass nodules in lung with spectral CT imaging].Zhonghua Yi Xue Za Zhi. 2021 Dec 7;101(45):3742-3747. doi: 10.3760/cma.j.cn112137-20210423-00972. Zhonghua Yi Xue Za Zhi. 2021. PMID: 34856703 Chinese.
-
Assessing the Blood Supply Status of the Focal Ground-Glass Opacity in Lungs Using Spectral Computed Tomography.Korean J Radiol. 2018 Jan-Feb;19(1):130-138. doi: 10.3348/kjr.2018.19.1.130. Epub 2018 Jan 2. Korean J Radiol. 2018. PMID: 29354009 Free PMC article.
-
Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.Eur J Radiol. 2015 Dec;84(12):2470-6. doi: 10.1016/j.ejrad.2015.09.023. Epub 2015 Oct 1. Eur J Radiol. 2015. PMID: 26481480
Cited by
-
Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma.Pak J Med Sci. 2023 May-Jun;39(3):742-746. doi: 10.12669/pjms.39.3.7397. Pak J Med Sci. 2023. PMID: 37250563 Free PMC article.
-
A prospective study of dual-energy computed tomography for differentiating metastatic and non-metastatic lymph nodes of colorectal cancer.Quant Imaging Med Surg. 2021 Aug;11(8):3448-3459. doi: 10.21037/qims-20-3. Quant Imaging Med Surg. 2021. PMID: 34341722 Free PMC article.
-
Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.Quant Imaging Med Surg. 2022 Feb;12(2):1243-1256. doi: 10.21037/qims-21-650. Quant Imaging Med Surg. 2022. PMID: 35111620 Free PMC article.
-
Dual-energy computed tomography for predicting histological grading and survival in patients with pancreatic ductal adenocarcinoma.Eur Radiol. 2025 May;35(5):2818-2832. doi: 10.1007/s00330-024-11109-4. Epub 2024 Oct 16. Eur Radiol. 2025. PMID: 39414655
-
Application of artificial intelligence-based dual source CT scanning in the differentiation of lung adenocarcinoma in situ and minimally invasive adenocarcinoma.Pak J Med Sci. 2024 Jan-Feb;40(3Part-II):271-276. doi: 10.12669/pjms.40.3.8454. Pak J Med Sci. 2024. PMID: 38356825 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210. - PubMed
-
- Soria JC, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, et al. Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8):an open-label randomised controlled phase 3 trial. Lancet Oncol. 2015;16(8):897–907. doi:10.1016/S1470-2045(15)00006-6. - PubMed
-
- Simons D, Kachelriess M, Schlemmer HP. Recent developments of dual-energy CT in oncology. Eur Radiol. 2014;24(4):930–939. doi:10.1007/s00330-013-3087-4. - PubMed
-
- Ma ZS, Zhao Q, Sun XB, Wang XY, Deng K, Pang T, et al. Spectral parameters analysis of spectral CT in clear cell renal cell carcinoma:correlation with tumor pathologic differentiation. J Med Imaging. 2013;23(10):1592–1596.
-
- Wu L, Zha YF, Zhao YL, Lin X, Xing D. Dual Energy CT Technique in the Diagnosis of Solitary Pulmonary Nodules:A Meta-Analysis. Med J Wuhan Univ. 2013;34(6):965–969.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials